Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05027477 · ClinicalTrials.gov registry record · NA
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer
A NA study of Prostate Cancer and Prostate Adenocarcinoma, sponsored by Profound Medical.
- Active
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 20
- Study locations
NCT05027477 is a NA study of Prostate Cancer and Prostate Adenocarcinoma that is active but no longer recruiting, run by Profound Medical. The registered enrollment target is 201 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (67% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT05027477, a NA study of Prostate Cancer and Prostate Adenocarcinoma, is active but no longer recruiting, sponsored by Profound Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 20
- Study locations
Study Summary
Men with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy.
Conditions Studied
Interventions
- DEVICE TULSA Procedure
- DEVICE Radical Prostatectomy
Study Locations (20)
California
- Atlantic Urology Medical Group - Long Beach
- Urology Group of Southern California - Los Angeles
- University of California, Los Angeles - Los Angeles
- Comprehensive Urology Medical Group - Los Angeles
- Alarcon Urology Center - Montebello
- Pasadena Urological Medical Group - Pasadena
- Stanford Cancer Center - Stanford
Arizona
- Arizona State Urological Institute - Chandler
- East Valley Urological Center - Mesa
- Investigate MD - Scottsdale
Florida
- Mayo Clinic Jacksonville - Jacksonville
- Sarasota Memorial Health Care System - Sarasota
Texas
- The University of Texas Southwestern Medical Center - Dallas
- The Urology Place - San Antonio
Connecticut
- Yale Cancer Center - New Haven
Indiana
- Indiana University - Indianapolis
Maryland
- Johns Hopkins School of Medicine - Baltimore
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2036-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05027477
The ClinicalTrials.gov registry entry for NCT05027477 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (67% lower). The listed sponsor is Profound Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which TULSA Procedure is the first listed.
NCT05027477 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT05027477 about?
NCT05027477 is a clinical study titled "A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer". Men with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe c...
What is the current status of trial NCT05027477?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 201 participants. The study started on 2021-11-01. Estimated completion is 2036-08-31.
What conditions does trial NCT05027477 study?
This clinical trial studies the following conditions: Prostate Cancer, Prostate Adenocarcinoma.
What interventions are being tested in trial NCT05027477?
The interventions under investigation include: TULSA Procedure (DEVICE), Radical Prostatectomy (DEVICE).
Who is sponsoring clinical trial NCT05027477?
This trial is sponsored by Profound Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05027477 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.